Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Clinical Research of Brandon, LLC

Neither a doctor nor a teaching hospital

Research payments

$1,450,367

54 payments

Through program year 2025, Clinical Research of Brandon, LLC is reported as receiving $1,450,367 in research payments, across 54 payments.

By program year

3 rows
Year Kind Amount Payments
2025 Research $980,073 37
2024 Research $439,990 14
2021 Research $30,304 3

Breakdown

Who paid Research payments · program years 2021–2025
  1. Axsome Therapeutics, Inc. $1,065,983 26 payments
  2. Novartis Pharmaceuticals Corporation $321,471 1 payment
  3. Sagent Pharmaceuticals, Inc. $30,304 3 payments
  4. Alnylam Pharmaceuticals Inc. $16,435 3 payments
  5. AstraZeneca UK Limited $10,320 1 payment
  6. Abbott Laboratories $5,853 20 payments
Studies the money was for Research payments · program years 2021–2025
  1. A Randomized, Double-blind, Active-controlled Study of AXS-05 for the Prevention of Relapse of Depressive Symptoms $1,065,983 26 payments
  2. A randomized, double-blind, placebo-controlled, multicenter, dose range finding study, to evaluate efficacy, safety and pharmacodynamics of QCZ484 in mild to moderate hypertensive patients $321,471 1 payment
  3. CAMELOT Trial (Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID19) $30,304 3 payments
  4. A Phase 3 Global, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Zilebesiran in Addition to Standard of Care in Reducing Major Adverse Cardiovascular Events in Adult Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease $16,435 3 payments
  5. Phase 2b Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Dose-Ranging Study to Assess the Efficacy, Safety, and Tolerability of AZD2373 in Participants with APOL1-Mediated Kidney Disease (APPRECIATE) $10,320 1 payment
  6. ISM2502013A--GLP-1 Optimization Therapy $5,853 20 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record